Healthcare professionals

Comprehensive disease characterization and therapeutic guidance Barrett's Esophagus can lead to adenocarcinoma     - One of the fastest growing incidence rates in the United States     - Endoscopic eradication of Barrett's Esophagus is complex and evolving    Current situation     - Adherence to guidelines is very limited and can lead to inefficient cancer detection (1)     - Treatment can be delayed until the next endoscopy procedure      - Repeat biopsies can alter treatment     - Endoscopy provides limited insight on the need to treat or re-treat, choice of treatment modality and evaluation of treatment completeness   Cellvizio Advantages (2-5)     - Immediate response and real-time treatment     - Smarter, more efficient surveillance     - Less invasive procedure     - Rule out malignancy “on the spot”     - Get the right treatment to the right patient Watch the short movie on the right to see Cellvizio in action during EGD.

References
1.Abrams J. et al., Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States, Clinical Gastroenterology and Hepatology, 2009.
2.Sharma P. et al., Real-time Increased Detection of Neoplastic Tissue in Barrett's Esophagus with probe-based Confocal Laser Endomicroscopy: Final Results of a Multi-center Prospective International Randomized Controlled Trial. ICCU 2011, Accepted for publication in Gastrointestinal Endoscopy.
3.Pohl H et al., Miniprobe Confocal Laser Microscopy for the Detection of Invisible Neoplasia in Patients with Barrett's Oesophagus. Gut. 2008.
4.Wallace MB et al., Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett’s esophagus with probe-based confocal laser endomicroscopy. GIE 2010.
5.Wallace M. et al,  Multicenter, Randomized Controlled Trial of Confocal Laser Endomicroscopy Assessment of Residual Neoplasia after Mucosal Ablation or Resection of Gastrointestinal Neoplasia in Barrett’s Esophagus (CLEAN MARGIN, BE), Preliminary Report, ICCU 2011, oral presentation.

Discover how you could start improving the management of your Barrett's patients with pCLE and which resources are available for you :

• Frequent and high-quality training opportunities
• A strong community of KOLs dedicated to the development of pCLE through the International Conference of Cellvizio Users
• Cellvizio.net: a complete e-learning center for Cellvizio users
• We can help you bring Cellvizio to your institution
• Frequently asked questions